This course offers an integrated approach on quality management in the pharma-ceutical, biotechnological, medical device industries and hospitals to safeguard the quality of their products. Expert knowledge and real life case studies are combined and presented and coached by professionals from Industry, Universities and Health Care Inspectorates. The training is interactive.

During this symposium, all current LACDR PhD-Students will present a poster. From each division one PhD will present his or her research in full during the LACDR PhD Competition. The winners will represent LACDR in the National Competition during the FIGON Medicine Days. 

The 6th International Symposium on Measurement and Kinetics of In Vivo Drug Effects will be held in Noordwijkerhout, The Netherlands, on April 21-24, 2010.

As with the previous symposia in 1990, 1994, 1998, 2002, and 2006, the purpose is to bring together scientists with an interest in in vivo Pharmacodynamic investigations to discuss the latest developments in the field of Pharmacokinetic-Pharmacodynamic (PKPD) modelling.

The development of new drugs has become largely dependent on a deeper understanding of human (patho)physiology. Nowadays, pharmacology and toxicology, both in vitro and in vivo, are essential to exploit fundamental knowledge for the development of drug candidates. As a consequence, both disciplines are more and more applied at an early stage of drug design to guide synthetic strategies.

Biopharmaceuticals have become an important category of drugs for the treatment and prevention of a variety of chronic and life-threatening diseases. In several aspects biopharmaceuticals differ from conventional, low-molecular-weight drugs, which has a major impact on the way they are developed.